Wang C, Feng L, Tu S, Wei D, Wang R, Deng Z
Eur J Med Res. 2025; 30(1):18.
PMID: 39780283
PMC: 11715515.
DOI: 10.1186/s40001-024-02226-3.
Ho V, Cenzer I, Nguyen B, Lee S
J Am Geriatr Soc. 2022; 70(5):1558-1568.
PMID: 35137952
PMC: 9106841.
DOI: 10.1111/jgs.17684.
Salam A, Huffman M, Kanukula R, Hari Prasad E, Sharma A, Heller D
J Clin Hypertens (Greenwich). 2020; 22(10):1769-1779.
PMID: 32815663
PMC: 8030031.
DOI: 10.1111/jch.14009.
Bejot Y
J Neurol. 2019; 268(3):785-795.
PMID: 31243539
DOI: 10.1007/s00415-019-09443-5.
Musini V, Tejani A, Bassett K, Puil L, Wright J
Cochrane Database Syst Rev. 2019; 6:CD000028.
PMID: 31167038
PMC: 6550717.
DOI: 10.1002/14651858.CD000028.pub3.
Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack.
Zonneveld T, Richard E, Vergouwen M, Nederkoorn P, de Haan R, Roos Y
Cochrane Database Syst Rev. 2018; 7:CD007858.
PMID: 30024023
PMC: 6513249.
DOI: 10.1002/14651858.CD007858.pub2.
First-line drugs for hypertension.
Wright J, Musini V, Gill R
Cochrane Database Syst Rev. 2018; 4:CD001841.
PMID: 29667175
PMC: 6513559.
DOI: 10.1002/14651858.CD001841.pub3.
Pharmacotherapy for hypertension in adults aged 18 to 59 years.
Musini V, Gueyffier F, Puil L, Salzwedel D, Wright J
Cochrane Database Syst Rev. 2017; 8:CD008276.
PMID: 28813123
PMC: 6483466.
DOI: 10.1002/14651858.CD008276.pub2.
Blood Pressure Management for Stroke Prevention and in Acute Stroke.
Hong K
J Stroke. 2017; 19(2):152-165.
PMID: 28592775
PMC: 5466289.
DOI: 10.5853/jos.2017.00164.
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals.
Taverny G, Mimouni Y, LeDigarcher A, Chevalier P, Thijs L, Wright J
Cochrane Database Syst Rev. 2016; 3:CD011745.
PMID: 26961575
PMC: 8665834.
DOI: 10.1002/14651858.CD011745.pub2.
Lowering of blood pressure for recurrent stroke prevention.
Boan A, Lackland D, Ovbiagele B
Stroke. 2014; 45(8):2506-13.
PMID: 24984744
PMC: 4134881.
DOI: 10.1161/STROKEAHA.114.003666.
Lifestyle factors in hypertension drug research: systematic analysis of articles in a leading cochrane report.
Wilson D, Van Vlack T, Schievink B, Doak E, Shane J, Dean E
Int J Hypertens. 2014; 2014:835716.
PMID: 24678418
PMC: 3941954.
DOI: 10.1155/2014/835716.
Hypertension: is the sham procedure 'toxic' for renal denervation?.
Tsioufis C
Nat Rev Nephrol. 2014; 10(4):186-7.
PMID: 24595040
DOI: 10.1038/nrneph.2014.28.
Hypertension in the elderly.
Hutchison B
Can Fam Physician. 2011; 27:1579-86.
PMID: 21289820
PMC: 2306196.
A practical approach to hypertension.
Dodek A, Wilkins G
Can Fam Physician. 2010; 22:61-73.
PMID: 20469276
PMC: 2378364.
Treatment of elderly hypertensive patients with epithelial sodium channel inhibitors combined with a thiazide diuretic reduces coronary mortality and sudden cardiac death.
Hebert P, Coffey C, Byrne D, Scott T, Fagard R, Rottman J
J Am Soc Hypertens. 2009; 2(5):355-65.
PMID: 19727429
PMC: 2633478.
DOI: 10.1016/j.jash.2008.04.001.
Secondary prevention of stroke by blood pressure-lowering treatment.
Arima H, Chalmers J
Curr Hypertens Rep. 2006; 8(4):317-23.
PMID: 16884663
DOI: 10.1007/s11906-006-0071-2.
[Blood pressure and the brain].
Hartmann A, Moskau S
Internist (Berl). 2005; 46(5):520-37.
PMID: 15834541
DOI: 10.1007/s00108-005-1406-9.
Generalizability of guidelines and physicians' adherence. Case study on the Sixth Joint National Commitee's guidelines on hypertension.
Pedone C, Lapane K
BMC Public Health. 2003; 3:24.
PMID: 12873353
PMC: 183849.
DOI: 10.1186/1471-2458-3-24.
Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials.
Wang J, Staessen J
J Clin Hypertens (Greenwich). 2003; 5(1):66-75.
PMID: 12556657
PMC: 8101815.
DOI: 10.1111/j.1524-6175.2003.01307.x.
